INTERNATIONAL PATENT: NEWAMSTERDAM PHARMA B.V. FILES APPLICATION FOR "TREATMENT AND PREVENTION OF SEPSIS OR OTHER DYSREGULATED INFLAMMATORY RESPONSES USING CETP INHIBITOR OBICETRAPIB"

GENEVA, May 4 -- NEWAMSTERDAM PHARMA B.V. (Gooimeer 2 351411 DC Naarden) filed a patent application (PCT/IB2024/000595) for "TREATMENT AND PREVENTION OF SEPSIS OR OTHER DYSREGULATED INFLAMMATORY RESPONSES USING CETP INHIBITOR OBICETRAPIB" on Oct 25, 2024. With publication no. WO/2026/087915, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KASTELEIN, Johannes, Jacob Pieter (Gooimeer 2 351411 DC Naarden), DAVIDSON, Michael, Harvey (p/a Gooimeer 2-351411 DC Naarden)

Abstract: This invention relates to methods and compositio...